<DOC>
	<DOCNO>NCT01382329</DOCNO>
	<brief_summary>The purpose study obtain immunogenicity safety data two different dose level H5N1 pandemic influenza vaccine healthy Japanese adult population age 18 59 year .</brief_summary>
	<brief_title>H5N1 Vaccine Study Japanese Adults</brief_title>
	<detailed_description />
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Influenza Birds</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Subject 18 59 year old time screen Subject generally healthy , determined investigator´s clinical judgement collection medical history performance physical examination Subject physically mentally capable participate study willing adhere study procedure include completion element study diary If female childbearing potential , subject present negative urine pregnancy test result within 24 hour prior ot schedule first vaccination agree employ adequate birth control measure duration study Subject history infectin H5N1 virus history vaccination H5N1 influenza vaccine Subject high risk contract H5N1 influenza infection ( e.g . poultry worker ) Subject currently history significant cardiovascular ( include hypertension ) , respiratory ( include asthma ) , metabolic , neurological ( include GuillainBarré Syndrome acute disseminate encephalomyelitis ) , hepatic , rheumatic , autoimmune , hematological , gastrointestinal renal disorder Subject inherit acquire immunodeficiency Subject disease currently undergoing form treatment undergoing form treatment within 30 day prior study entry expect influence immune response . Such treatment include , limited : systemic inhaled corticosteroid , radiation treatment , immunosuppressive cytotoxic drug Subject history severe allergic reaction anaphylaxis Subject rash , dermatologic condition tattoo may interfere injection site reaction rating Subject receive blood transfusion immunoglobulin within 90 day prior study entry Subject donate blood plasma within 30 day prior study entry Subject receive influenza live vaccine within 4 week inactivate vaccine within 2 week prior vaccination study Subject functional surgical asplenia Subject know suspect problem alcohol drug abuse Subject administer investigational drug within 6 week prior study entry concurrently participate clinical study include administration investigational product Subject member team conduct study dependent relationship one study team member . Dependent relationship include close relative ( i.e. , child , partner/spouse , sibling , parent ) well employee investigator/subinvestigator site personnel conduct study If female , subject pregnant lactating time enrollment Subject condition disqualify his/her participation study opinion investigator</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>59 Years</maximum_age>
	<verification_date>September 2012</verification_date>
	<keyword>Prophylaxis influenza infection cause pandemic influenza virus ( H5N1 )</keyword>
</DOC>